ID   C1R_HUMAN               Reviewed;         705 AA.
AC   P00736; A6NJQ8; Q68D77; Q8J012;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   22-FEB-2023, entry version 246.
DE   RecName: Full=Complement C1r subcomponent;
DE            EC=3.4.21.41;
DE   AltName: Full=Complement component 1 subcomponent r;
DE   Contains:
DE     RecName: Full=Complement C1r subcomponent heavy chain;
DE   Contains:
DE     RecName: Full=Complement C1r subcomponent light chain;
DE   Flags: Precursor;
GN   Name=C1R;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-186.
RX   PubMed=3021205; DOI=10.1021/bi00365a020;
RA   Leytus S.P., Kurachi K., Sakariassen K.S., Davie E.W.;
RT   "Nucleotide sequence of the cDNA coding for human complement C1r.";
RL   Biochemistry 25:4855-4863(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LEU-152 AND ARG-186.
RX   PubMed=3030286; DOI=10.1042/bj2400783;
RA   Journet A., Tosi M.;
RT   "Cloning and sequencing of full-length cDNA encoding the precursor of human
RT   complement component C1r.";
RL   Biochem. J. 240:783-787(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-131; LEU-152; TYR-163;
RP   LYS-184; ARG-186 AND ARG-261.
RX   PubMed=12914573; DOI=10.1046/j.1469-1809.2003.00019.x;
RA   Nakagawa M., Yuasa I., Irizawa Y., Umetsu K.;
RT   "The human complement component C1R gene: the exon-intron structure and the
RT   molecular basis of allelic diversity.";
RL   Ann. Hum. Genet. 67:207-215(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-152 AND ARG-186.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 18-463.
RX   PubMed=3036070; DOI=10.1042/bj2410711;
RA   Arlaud G.J., Willis A.C., Gagnon J.;
RT   "Complete amino acid sequence of the A chain of human complement-classical-
RT   pathway enzyme C1r.";
RL   Biochem. J. 241:711-720(1987).
RN   [8]
RP   PROTEIN SEQUENCE OF 464-705.
RX   PubMed=6303394; DOI=10.1021/bi00277a003;
RA   Arlaud G.J., Gagnon J.;
RT   "Complete amino acid sequence of the catalytic chain of human complement
RT   subcomponent C1-r.";
RL   Biochemistry 22:1758-1764(1983).
RN   [9]
RP   PROTEIN SEQUENCE OF 152-186, AND HYDROXYLATION AT ASN-167.
RX   PubMed=2820791; DOI=10.1016/0014-5793(87)80205-3;
RA   Arlaud G.J., van Dorsselaer A., Bell A., Mancini M., Aude C., Gagnon J.;
RT   "Identification of erythro-beta-hydroxyasparagine in the EGF-like domain of
RT   human C1r.";
RL   FEBS Lett. 222:129-134(1987).
RN   [10]
RP   PROTEIN SEQUENCE OF 133-137; 187-211 AND 609-613, AND PHOSPHORYLATION AT
RP   SER-206 BY CK2.
RX   PubMed=8635594; DOI=10.1016/0014-5793(96)00403-6;
RA   Pelloux S., Thielens N.M., Hudry-Clergeon G., Petillot Y., Filhol O.,
RA   Arlaud G.J.;
RT   "Identification of a cryptic protein kinase CK2 phosphorylation site in
RT   human complement protease Clr, and its use to probe intramolecular
RT   interaction.";
RL   FEBS Lett. 386:15-20(1996).
RN   [11]
RP   POSSIBLE INVOLVEMENT IN C1R DEFICIENCY.
RX   PubMed=2831944; DOI=10.1021/bi00400a004;
RA   Tosi M., Duponchel C., Meo T., Julier C.;
RT   "Complete cDNA sequence of human complement Cls and close physical linkage
RT   of the homologous genes Cls and Clr.";
RL   Biochemistry 26:8516-8524(1987).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125; ASN-221 AND ASN-514.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-514.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUBCELLULAR LOCATION, INVOLVEMENT IN EDSPD1, VARIANTS EDSPD1 ASP-50;
RP   GLY-290; ASP-297; PRO-300; PRO-301; CYS-302; 306-ILE--CYS-309 DELINS
RP   ARG-ARG; TRP-309; ARG-338; PHE-358; CYS-364; TRP-371; 401-ARG--TYR-405
RP   DELINS HIS-VAL-ILE AND ARG-435, AND CHARACTERIZATION OF VARIANTS EDSPD1
RP   ASP-50; TRP-309 AND TRP-371.
RX   PubMed=27745832; DOI=10.1016/j.ajhg.2016.08.019;
RG   Molecular Basis of Periodontal EDS Consortium;
RA   Kapferer-Seebacher I., Pepin M., Werner R., Aitman T.J., Nordgren A.,
RA   Stoiber H., Thielens N., Gaboriaud C., Amberger A., Schossig A., Gruber R.,
RA   Giunta C., Bamshad M., Bjoerck E., Chen C., Chitayat D., Dorschner M.,
RA   Schmitt-Egenolf M., Hale C.J., Hanna D., Hennies H.C.,
RA   Heiss-Kisielewsky I., Lindstrand A., Lundberg P., Mitchell A.L.,
RA   Nickerson D.A., Reinstein E., Rohrbach M., Romani N., Schmuth M.,
RA   Silver R., Taylan F., Vandersteen A., Vandrovcova J., Weerakkody R.,
RA   Yang M., Pope F.M., Byers P.H., Zschocke J.;
RT   "Periodontal Ehlers-Danlos syndrome is caused by mutations in C1R and C1S,
RT   which encode subcomponents C1r and C1s of complement.";
RL   Am. J. Hum. Genet. 99:1005-1014(2016).
RN   [16]
RP   STRUCTURE BY NMR OF 140-192.
RX   PubMed=9477945; DOI=10.1021/bi971851v;
RA   Bersch B., Hernandez J.-F., Marion D., Arlaud G.J.;
RT   "Solution structure of the epidermal growth factor (EGF)-like module of
RT   human complement protease C1r, an atypical member of the EGF family.";
RL   Biochemistry 37:1204-1214(1998).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 307-702.
RX   PubMed=11823416; DOI=10.1093/emboj/21.3.231;
RA   Budayova-Spano M., Lacroix M., Thielens N.M., Arlaud G.J.,
RA   Fontecilla-Camps J.-C., Gaboriaud C.;
RT   "The crystal structure of the zymogen catalytic domain of complement
RT   protease C1r reveals that a disruptive mechanical stress is required to
RT   trigger activation of the C1 complex.";
RL   EMBO J. 21:231-239(2002).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 375-702.
RX   PubMed=12429092; DOI=10.1016/s0969-2126(02)00881-x;
RA   Budayova-Spano M., Grabarse W., Thielens N.M., Hillen H., Lacroix M.,
RA   Schmidt M., Fontecilla-Camps J.-C., Arlaud G.J., Gaboriaud C.;
RT   "Monomeric structures of the zymogen and active catalytic domain of
RT   complement protease c1r: further insights into the c1 activation
RT   mechanism.";
RL   Structure 10:1509-1519(2002).
RN   [19]
RP   VARIANT LEU-152.
RX   PubMed=8162045; DOI=10.1093/hmg/3.1.217-a;
RA   Nothen M.M., Dewald G.;
RT   "A common amino acid polymorphism in complement component C1R.";
RL   Hum. Mol. Genet. 3:217-217(1994).
RN   [20]
RP   VARIANTS LYS-184 AND ARG-261, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22028381; DOI=10.1093/jmcb/mjr024;
RA   Su Z.D., Sun L., Yu D.X., Li R.X., Li H.X., Yu Z.J., Sheng Q.H., Lin X.,
RA   Zeng R., Wu J.R.;
RT   "Quantitative detection of single amino acid polymorphisms by targeted
RT   proteomics.";
RL   J. Mol. Cell Biol. 3:309-315(2011).
CC   -!- FUNCTION: C1r B chain is a serine protease that combines with C1q and
CC       C1s to form C1, the first component of the classical pathway of the
CC       complement system.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Selective cleavage of Lys(or Arg)-|-Ile bond in complement
CC         subcomponent C1s to form the active form of C1s (EC 3.4.21.42).;
CC         EC=3.4.21.41;
CC   -!- SUBUNIT: C1 is a calcium-dependent trimolecular complex of C1q, C1r and
CC       C1s in the molar ration of 1:2:2. C1r is a dimer of identical chains,
CC       each of which is activated by cleavage into two chains, A and B,
CC       connected by disulfide bonds.
CC   -!- INTERACTION:
CC       P00736; P00736: C1R; NbExp=2; IntAct=EBI-3926504, EBI-3926504;
CC       P00736; P09871: C1S; NbExp=6; IntAct=EBI-3926504, EBI-2810045;
CC       P00736; P05155: SERPING1; NbExp=2; IntAct=EBI-3926504, EBI-1223454;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:27745832}.
CC   -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate
CC       and asparagine is (R) stereospecific within EGF domains.
CC       {ECO:0000269|PubMed:2820791}.
CC   -!- POLYMORPHISM: Complement component C1r deficiency [MIM:216950] leads to
CC       the failure of the classical complement system activation pathway (C1
CC       deficiency). Individuals with C1 deficiency are highly susceptible to
CC       infections by microorganisms and have greater risk in developing
CC       autoimmune diseases such as systemic lupus erythematosus (SLE).
CC       {ECO:0000269|PubMed:2831944}.
CC   -!- DISEASE: Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1)
CC       [MIM:130080]: A form of Ehlers-Danlos syndrome, a connective tissue
CC       disorder characterized by hyperextensible skin, atrophic cutaneous
CC       scars due to tissue fragility and joint hyperlaxity. EDSPD1 is
CC       characterized by the association of typical features of Ehlers-Danlos
CC       syndrome with gingival recession and severe early-onset periodontal
CC       disease, leading to premature loss of permanent teeth. EDSPD1
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:27745832}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14058; AAA51851.1; -; mRNA.
DR   EMBL; X04701; CAA28407.1; -; mRNA.
DR   EMBL; AB083037; BAC19850.2; -; Genomic_DNA.
DR   EMBL; AC094008; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140077; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR749540; CAH18343.1; -; mRNA.
DR   EMBL; BC035220; AAH35220.1; -; mRNA.
DR   CCDS; CCDS81658.1; -.
DR   PIR; A24170; C1HURB.
DR   RefSeq; NP_001724.3; NM_001733.4.
DR   PDB; 1APQ; NMR; -; A=140-192.
DR   PDB; 1GPZ; X-ray; 2.90 A; A/B=307-705.
DR   PDB; 1MD7; X-ray; 3.20 A; A=375-702.
DR   PDB; 1MD8; X-ray; 2.80 A; A=375-703.
DR   PDB; 2QY0; X-ray; 2.60 A; A/C=309-463, B/D=464-705.
DR   PDB; 6F1C; X-ray; 4.20 A; A/C=18-308.
DR   PDB; 6F1D; X-ray; 1.95 A; A=191-307.
DR   PDB; 6F1H; X-ray; 4.50 A; A/C=18-308.
DR   PDB; 6F39; X-ray; 5.80 A; A/B=22-306.
DR   PDBsum; 1APQ; -.
DR   PDBsum; 1GPZ; -.
DR   PDBsum; 1MD7; -.
DR   PDBsum; 1MD8; -.
DR   PDBsum; 2QY0; -.
DR   PDBsum; 6F1C; -.
DR   PDBsum; 6F1D; -.
DR   PDBsum; 6F1H; -.
DR   PDBsum; 6F39; -.
DR   AlphaFoldDB; P00736; -.
DR   SASBDB; P00736; -.
DR   SMR; P00736; -.
DR   BioGRID; 107176; 14.
DR   ComplexPortal; CPX-1920; Complement C1 complex.
DR   IntAct; P00736; 11.
DR   MINT; P00736; -.
DR   STRING; 9606.ENSP00000438615; -.
DR   BindingDB; P00736; -.
DR   ChEMBL; CHEMBL4611; -.
DR   DrugBank; DB09228; Conestat alfa.
DR   DrugBank; DB00111; Daclizumab.
DR   DrugBank; DB12831; Gabexate.
DR   DrugBank; DB06404; Human C1-esterase inhibitor.
DR   DrugBank; DB00110; Palivizumab.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugBank; DB14548; Zinc sulfate, unspecified form.
DR   DrugCentral; P00736; -.
DR   GuidetoPHARMACOLOGY; 2334; -.
DR   MEROPS; S01.192; -.
DR   GlyConnect; 713; 17 N-Linked glycans (3 sites).
DR   GlyCosmos; P00736; 4 sites, 17 glycans.
DR   GlyGen; P00736; 4 sites, 2 Asn glycans (2 sites), 17 N-linked glycans (3 sites).
DR   iPTMnet; P00736; -.
DR   PhosphoSitePlus; P00736; -.
DR   BioMuta; C1R; -.
DR   DMDM; 218511956; -.
DR   EPD; P00736; -.
DR   jPOST; P00736; -.
DR   MassIVE; P00736; -.
DR   PeptideAtlas; P00736; -.
DR   ProteomicsDB; 51270; -.
DR   DNASU; 715; -.
DR   GeneID; 715; -.
DR   KEGG; hsa:715; -.
DR   UCSC; uc031ysf.2; human.
DR   AGR; HGNC:1246; -.
DR   CTD; 715; -.
DR   DisGeNET; 715; -.
DR   GeneCards; C1R; -.
DR   GeneReviews; C1R; -.
DR   HGNC; HGNC:1246; C1R.
DR   MalaCards; C1R; -.
DR   MIM; 130080; phenotype.
DR   MIM; 216950; phenotype.
DR   MIM; 613785; gene.
DR   neXtProt; NX_P00736; -.
DR   Orphanet; 300345; Autosomal systemic lupus erythematosus.
DR   Orphanet; 169147; Immunodeficiency due to a classical component pathway complement deficiency.
DR   Orphanet; 75392; Periodontal Ehlers-Danlos syndrome.
DR   PharmGKB; PA25635; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   InParanoid; P00736; -.
DR   OrthoDB; 5394076at2759; -.
DR   PhylomeDB; P00736; -.
DR   TreeFam; TF330373; -.
DR   BRENDA; 3.4.21.41; 2681.
DR   PathwayCommons; P00736; -.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-173623; Classical antibody-mediated complement activation.
DR   Reactome; R-HSA-977606; Regulation of Complement cascade.
DR   SABIO-RK; P00736; -.
DR   SignaLink; P00736; -.
DR   SIGNOR; P00736; -.
DR   BioGRID-ORCS; 715; 5 hits in 240 CRISPR screens.
DR   ChiTaRS; C1R; human.
DR   EvolutionaryTrace; P00736; -.
DR   GeneWiki; C1R_(gene); -.
DR   GenomeRNAi; 715; -.
DR   Pharos; P00736; Tclin.
DR   PRO; PR:P00736; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P00736; protein.
DR   Genevisible; P00736; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005602; C:complement component C1 complex; NAS:ComplexPortal.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:CAFA.
DR   GO; GO:0005509; F:calcium ion binding; IDA:CAFA.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140313; F:molecular sequestering activity; EXP:DisProt.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; EXP:Reactome.
DR   GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0006958; P:complement activation, classical pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0031638; P:zymogen activation; IDA:CAFA.
DR   CDD; cd00033; CCP; 2.
DR   CDD; cd00041; CUB; 2.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   DisProt; DP00621; -.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 2.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 2.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 3.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR024175; Pept_S1A_C1r/C1S/mannan-bd.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24255:SF25; COMPLEMENT C1R SUBCOMPONENT; 1.
DR   PANTHER; PTHR24255; COMPLEMENT COMPONENT 1, S SUBCOMPONENT-RELATED; 1.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF14670; FXa_inhibition; 1.
DR   Pfam; PF00084; Sushi; 2.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001155; C1r_C1s_MASP; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00032; CCP; 2.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00179; EGF_CA; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57535; Complement control module/SCR domain; 2.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF49854; Spermadhesin, CUB domain; 2.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS50923; SUSHI; 2.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complement pathway; Direct protein sequencing;
KW   Disease variant; Disulfide bond; EGF-like domain; Ehlers-Danlos syndrome;
KW   Glycoprotein; Hydrolase; Hydroxylation; Immunity; Innate immunity;
KW   Phosphoprotein; Protease; Reference proteome; Repeat; Secreted;
KW   Serine protease; Signal; Sushi.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000269|PubMed:3036070"
FT   CHAIN           18..705
FT                   /note="Complement C1r subcomponent"
FT                   /id="PRO_0000027577"
FT   CHAIN           18..463
FT                   /note="Complement C1r subcomponent heavy chain"
FT                   /id="PRO_0000027578"
FT   CHAIN           464..705
FT                   /note="Complement C1r subcomponent light chain"
FT                   /id="PRO_0000027579"
FT   DOMAIN          18..141
FT                   /note="CUB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          142..190
FT                   /note="EGF-like; calcium-binding"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          193..305
FT                   /note="CUB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          307..373
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          374..449
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          464..702
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        502
FT                   /note="Charge relay system"
FT   ACT_SITE        557
FT                   /note="Charge relay system"
FT   ACT_SITE        654
FT                   /note="Charge relay system"
FT   MOD_RES         167
FT                   /note="(3R)-3-hydroxyasparagine"
FT                   /evidence="ECO:0000269|PubMed:2820791"
FT   MOD_RES         206
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:8635594"
FT   CARBOHYD        125
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        221
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        514
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        581
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   DISULFID        71..89
FT                   /evidence="ECO:0000305"
FT   DISULFID        146..165
FT   DISULFID        161..174
FT   DISULFID        176..189
FT   DISULFID        193..220
FT                   /evidence="ECO:0000305"
FT   DISULFID        250..268
FT                   /evidence="ECO:0000305"
FT   DISULFID        309..358
FT   DISULFID        338..371
FT   DISULFID        376..429
FT   DISULFID        406..447
FT   DISULFID        451..577
FT                   /note="Interchain (between heavy and light chains)"
FT   DISULFID        620..639
FT   DISULFID        650..680
FT   VARIANT         50
FT                   /note="V -> D (in EDSPD1; requires 2 nucleotide
FT                   substitutions; the mutant is not secreted but retained
FT                   intracellularly)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077106"
FT   VARIANT         131
FT                   /note="Y -> H (in dbSNP:rs1278295523)"
FT                   /evidence="ECO:0000269|PubMed:12914573"
FT                   /id="VAR_018667"
FT   VARIANT         152
FT                   /note="S -> L (in dbSNP:rs1801046)"
FT                   /evidence="ECO:0000269|PubMed:12914573,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:3030286,
FT                   ECO:0000269|PubMed:8162045"
FT                   /id="VAR_016103"
FT   VARIANT         163
FT                   /note="H -> Y (in dbSNP:rs144141261)"
FT                   /evidence="ECO:0000269|PubMed:12914573"
FT                   /id="VAR_018668"
FT   VARIANT         184
FT                   /note="E -> K (confirmed at protein level;
FT                   dbSNP:rs1126605)"
FT                   /evidence="ECO:0000269|PubMed:12914573,
FT                   ECO:0000269|PubMed:22028381"
FT                   /id="VAR_018669"
FT   VARIANT         186
FT                   /note="T -> R (in dbSNP:rs4519167)"
FT                   /evidence="ECO:0000269|PubMed:12914573,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:3021205,
FT                   ECO:0000269|PubMed:3030286"
FT                   /id="VAR_047933"
FT   VARIANT         261
FT                   /note="G -> R (confirmed at protein level;
FT                   dbSNP:rs3813728)"
FT                   /evidence="ECO:0000269|PubMed:12914573,
FT                   ECO:0000269|PubMed:22028381"
FT                   /id="VAR_018670"
FT   VARIANT         290
FT                   /note="D -> G (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs1057518643)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077107"
FT   VARIANT         297
FT                   /note="G -> D (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs1057519026)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077108"
FT   VARIANT         300
FT                   /note="L -> P (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs1057515579)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077109"
FT   VARIANT         301
FT                   /note="R -> P (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs760277934)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077110"
FT   VARIANT         302
FT                   /note="Y -> C (in EDSPD1; dbSNP:rs1057519576)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077111"
FT   VARIANT         306..309
FT                   /note="IIKC -> RR (in EDSPD1)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077112"
FT   VARIANT         309
FT                   /note="C -> W (in EDSPD1; the mutant is not secreted but
FT                   retained intracellularly; dbSNP:rs769707492)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077113"
FT   VARIANT         338
FT                   /note="C -> R (in EDSPD1; dbSNP:rs1057519577)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077114"
FT   VARIANT         358
FT                   /note="C -> F (in EDSPD1; dbSNP:rs1057518645)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077115"
FT   VARIANT         364
FT                   /note="W -> C (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs1057519578)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077116"
FT   VARIANT         371
FT                   /note="C -> W (in EDSPD1; the mutant is not secreted but
FT                   retained intracellularly; dbSNP:rs1057519579)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077117"
FT   VARIANT         401..405
FT                   /note="RIQYY -> HVI (in EDSPD1; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077118"
FT   VARIANT         435
FT                   /note="W -> R (in EDSPD1; unknown pathological
FT                   significance; dbSNP:rs1060499554)"
FT                   /evidence="ECO:0000269|PubMed:27745832"
FT                   /id="VAR_077119"
FT   TURN            145..147
FT                   /evidence="ECO:0007829|PDB:1APQ"
FT   TURN            150..152
FT                   /evidence="ECO:0007829|PDB:1APQ"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:1APQ"
FT   STRAND          162..168
FT                   /evidence="ECO:0007829|PDB:1APQ"
FT   STRAND          171..175
FT                   /evidence="ECO:0007829|PDB:1APQ"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          200..206
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   TURN            208..211
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          219..225
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          230..236
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          246..250
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          254..259
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          262..267
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          281..288
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          299..306
FT                   /evidence="ECO:0007829|PDB:6F1D"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:1GPZ"
FT   STRAND          333..338
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          342..346
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          349..352
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          355..358
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          364..366
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          370..373
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          385..392
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          401..406
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   TURN            408..410
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          411..413
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          426..429
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          433..437
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   TURN            438..440
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          478..492
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   TURN            493..495
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          496..499
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           501..504
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          518..522
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           526..532
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          537..542
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          548..552
FT                   /evidence="ECO:0007829|PDB:1GPZ"
FT   STRAND          559..565
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          571..573
FT                   /evidence="ECO:0007829|PDB:1MD7"
FT   HELIX           582..585
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          590..595
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          600..602
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          608..614
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           617..626
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          637..641
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           643..650
FT                   /evidence="ECO:0007829|PDB:1GPZ"
FT   TURN            651..655
FT                   /evidence="ECO:0007829|PDB:1MD8"
FT   STRAND          657..661
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   TURN            663..665
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          668..676
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          678..683
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   STRAND          685..689
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           690..693
FT                   /evidence="ECO:0007829|PDB:2QY0"
FT   HELIX           694..700
FT                   /evidence="ECO:0007829|PDB:2QY0"
SQ   SEQUENCE   705 AA;  80119 MW;  B45D120201061462 CRC64;
     MWLLYLLVPA LFCRAGGSIP IPQKLFGEVT SPLFPKPYPN NFETTTVITV PTGYRVKLVF
     QQFDLEPSEG CFYDYVKISA DKKSLGRFCG QLGSPLGNPP GKKEFMSQGN KMLLTFHTDF
     SNEENGTIMF YKGFLAYYQA VDLDECASRS KSGEEDPQPQ CQHLCHNYVG GYFCSCRPGY
     ELQEDTHSCQ AECSSELYTE ASGYISSLEY PRSYPPDLRC NYSIRVERGL TLHLKFLEPF
     DIDDHQQVHC PYDQLQIYAN GKNIGEFCGK QRPPDLDTSS NAVDLLFFTD ESGDSRGWKL
     RYTTEIIKCP QPKTLDEFTI IQNLQPQYQF RDYFIATCKQ GYQLIEGNQV LHSFTAVCQD
     DGTWHRAMPR CKIKDCGQPR NLPNGDFRYT TTMGVNTYKA RIQYYCHEPY YKMQTRAGSR
     ESEQGVYTCT AQGIWKNEQK GEKIPRCLPV CGKPVNPVEQ RQRIIGGQKA KMGNFPWQVF
     TNIHGRGGGA LLGDRWILTA AHTLYPKEHE AQSNASLDVF LGHTNVEELM KLGNHPIRRV
     SVHPDYRQDE SYNFEGDIAL LELENSVTLG PNLLPICLPD NDTFYDLGLM GYVSGFGVME
     EKIAHDLRFV RLPVANPQAC ENWLRGKNRM DVFSQNMFCA GHPSLKQDAC QGDSGGVFAV
     RDPNTDRWVA TGIVSWGIGC SRGYGFYTKV LNYVDWIKKE MEEED
//
